Propellant Health creates Market Access for innovative medical technologies. Some of its results include: Created EMEA go-to-market strategies for Silicon Valley genetic testing & automated cervical cancer screening Determined go-to-market strategy and realized EMEA market access plan for Seattle-based Atossa Genetics; in breast cancer and pharmacogenomics Successfully co-founded Hemacon GmbH; start-up in veterinary and human blood management systems Created direct USA sales/service operations for producer of automated blood systems; revenues $10M+ Created go-to-market strategy for digital fundus camera based on scanning laser ophtalmoscope technology